These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21088056)

  • 1. β-cell function and metabolic control in latent autoimmune diabetes in adults with early insulin versus conventional treatment: a 3-year follow-up.
    Thunander M; Thorgeirsson H; Törn C; Petersson C; Landin-Olsson M
    Eur J Endocrinol; 2011 Feb; 164(2):239-45. PubMed ID: 21088056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and metabolic characteristics of patients with latent autoimmune diabetes in adults (LADA): absence of rapid beta-cell loss in patients with tight metabolic control.
    Chaillous L; Bouhanick B; Kerlan V; Mathieu E; Lecomte P; Ducluzeau PH; Delamaire M; Sonnet E; Maugendre D; Maréchaud R; Rohmer V; Saï P; Charbonnel B
    Diabetes Metab; 2010 Feb; 36(1):64-70. PubMed ID: 20060765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for latent autoimmune diabetes (LADA) in adults.
    Brophy S; Brunt H; Davies H; Mannan S; Williams R
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006165. PubMed ID: 17636829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial.
    Raz I; Avron A; Tamir M; Metzger M; Symer L; Eldor R; Cohen IR; Elias D
    Diabetes Metab Res Rev; 2007 May; 23(4):292-8. PubMed ID: 17124720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus.
    Maruyama T; Tanaka S; Shimada A; Funae O; Kasuga A; Kanatsuka A; Takei I; Yamada S; Harii N; Shimura H; Kobayashi T
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2115-21. PubMed ID: 18397986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA)--a 5-year follow-up of the Ehime study.
    Murao S; Kondo S; Ohashi J; Fujii Y; Shimizu I; Fujiyama M; Ohno K; Takada Y; Nakai K; Yamane Y; Osawa H; Makino H
    Diabetes Res Clin Pract; 2008 Apr; 80(1):114-21. PubMed ID: 18342387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating optimal β-cell-preserving treatment in latent autoimmune diabetes in adults: Results from a 21-month randomized trial.
    Hals IK; Fiskvik Fleiner H; Reimers N; Astor MC; Filipsson K; Ma Z; Grill V; Björklund A
    Diabetes Obes Metab; 2019 Oct; 21(10):2219-2227. PubMed ID: 31148332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin secretion measured by stimulated C-peptide in long-established Type 1 diabetes in the Diabetes Control and Complications Trial (DCCT)/ Epidemiology of Diabetes Interventions and Complications (EDIC) cohort: a pilot study.
    McGee P; Steffes M; Nowicki M; Bayless M; Gubitosi-Klug R; Cleary P; Lachin J; Palmer J;
    Diabet Med; 2014 Oct; 31(10):1264-8. PubMed ID: 24836354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of Spain.
    Mollo A; Hernandez M; Marsal JR; Esquerda A; Rius F; Blanco-Vaca F; Verdaguer J; Pozzilli P; de Leiva A; Mauricio D;
    Diabetes Metab Res Rev; 2013 Sep; 29(6):446-51. PubMed ID: 23483713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin secretion in patients with latent autoimmune diabetes (LADA): half way between type 1 and type 2 diabetes: action LADA 9.
    Hernandez M; Mollo A; Marsal JR; Esquerda A; Capel I; Puig-Domingo M; Pozzilli P; de Leiva A; Mauricio D;
    BMC Endocr Disord; 2015 Jan; 15():1. PubMed ID: 25572256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosiglitazone preserves islet beta-cell function of adult-onset latent autoimmune diabetes in 3 years follow-up study.
    Yang Z; Zhou Z; Li X; Huang G; Lin J
    Diabetes Res Clin Pract; 2009 Jan; 83(1):54-60. PubMed ID: 19008007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptidyl peptidase 4 inhibitor sitagliptin maintains β-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study.
    Zhao Y; Yang L; Xiang Y; Liu L; Huang G; Long Z; Li X; Leslie RD; Wang X; Zhou Z
    J Clin Endocrinol Metab; 2014 May; 99(5):E876-80. PubMed ID: 24432999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of heat shock protein peptide DiaPep277 on beta-cell function in paediatric and adult patients with recent-onset diabetes mellitus type 1: two prospective, randomized, double-blind phase II trials.
    Schloot NC; Meierhoff G; Lengyel C; Vándorfi G; Takács J; Pánczél P; Barkai L; Madácsy L; Oroszlán T; Kovács P; Sütö G; Battelino T; Hosszufalusi N; Jermendy G
    Diabetes Metab Res Rev; 2007 May; 23(4):276-85. PubMed ID: 17103487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes.
    Picardi A; Visalli N; Lauria A; Suraci C; Buzzetti R; Merola MK; Manfrini S; Guglielmi C; Gentilucci UV; Pitocco D; Crinò A; Bizzarri C; Cappa M; Pozzilli P
    Horm Metab Res; 2006 Oct; 38(10):668-72. PubMed ID: 17075776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence and characteristics of latent autoimmune diabetes in adults (LADA) and its relation with chronic complications in a clinical department of a university hospital in Korea.
    Roh MO; Jung CH; Kim BY; Mok JO; Kim CH
    Acta Diabetol; 2013 Apr; 50(2):129-34. PubMed ID: 20953640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA).
    Li X; Liao L; Yan X; Huang G; Lin J; Lei M; Wang X; Zhou Z
    Diabetes Metab Res Rev; 2009 Jul; 25(5):411-6. PubMed ID: 19488999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3).
    Liu L; Li X; Xiang Y; Huang G; Lin J; Yang L; Zhao Y; Yang Z; Hou C; Li Y; Liu J; Zhu D; Leslie RD; Wang X; Zhou Z;
    Diabetes Care; 2015 Jan; 38(1):16-21. PubMed ID: 25336751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus.
    Taha DR; Castells S; Umpaichitra V; Bastian W; Banerji MA
    J Pediatr Endocrinol Metab; 2002 Jan; 15(1):59-67. PubMed ID: 11822582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent Autoimmune Diabetes in Adults: Background, Safety and Feasibility of an Ongoing Pilot Study With Intra-Lymphatic Injections of GAD-Alum and Oral Vitamin D.
    Björklund A; Hals IK; Grill V; Ludvigsson J
    Front Endocrinol (Lausanne); 2022; 13():926021. PubMed ID: 35923626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of insulin versus sulphonylurea on beta-cell secretion in recently diagnosed type 2 diabetes patients: a 6-year follow-up study.
    Alvarsson M; Berntorp K; Fernqvist-Forbes E; Lager I; Steen L; Orn T; Grill V
    Rev Diabet Stud; 2010; 7(3):225-32. PubMed ID: 21409314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.